Register allocation: A program-algebraic approach

著者: Roger Stupp, Eric T. Wong, Andrew A. Kanner, David Steinberg, Herbert H. Engelhard, Volkmar Heidecke, Eilon D. Kirson, Sophie Taillibert, Frank Liebermann, Vladimír Dbalý, Zvi Ram, John L. Villano, Nikolai G. Rainov, Uri Weinberg, David Schiff, Lara J. Kunschner, Jeffrey J. Raizer, Jérôme Honnorat, Andrew E. Sloan, Mark G. Malkin, Joseph Landolfi, Franz Payer, H. Maximilian Mehdorn, Robert J. Weil, Susan C. Pannullo, Manfred Westphal, Martin Smrčka, Lawrence S. Chin, H. Kostron, Silvia Höfer, Jeffrey N. Bruce, Rees Cosgrove, Nina Paleologous, Yoram Palti, Philip H. Gutin - European Journal of Cancer 2001 被引用: 847

This is the first controlled trial evaluating an entirely novel cancer treatment modality delivering electric fields rather than chemotherapy. No improvement in overall survival was demonstrated, however efficacy and activity with this chemotherapy-free treatment device appears comparable to chemotherapy regimens that are commonly used for recurrent glioblastoma. Toxicity and quality of life clearly favoured TTF.